insight-driven, technology solution that was built with one pursuit—creating and sustaining a high performing culture through its most important asset, healthcare professionals. Using proprietary solutions and benchmarking method, Accumen Technology enables real-time information for healthcare decision making across the full spectrum of the laboratory, Imaging, and Patient Blood Management. Accumen’s innovative technology combined with health system service offerings optimizes hospitals and health systems for increased productivity, higher quality, patient safety, better service and unprecedented value to create healthier labs, healthier hospitals, and ultimately, healthier communities. Accumen launched its first software-as-a-service (SaaS) solution, MyBloodHealth®, a hospital-based tele health anemia management program with both perioperative and comprehensive blood management options. The product connects all providers involved in a patient’s care directly through the health system’s electronic health record system, making it an easy-to-use resource in the care continuum. “I am very excited to introduce MyBloodHealth to hospitals and health systems nationally. This clinician-created patient blood management solution includes personalized care plans, analytics, and training all on a virtual platform. MyBloodHealth has already proven to reduce healthcare costs through a combination of length of stay reductions, new revenue from infusion medications and reduced blood utilization,” adds BG Porter, Accumen’s CEO. Alongside the patient blood management (PBM) programs help to address a big problem in healthcare: the overuse of blood transfusions. If an organization has started or is considering a PBM program, Accumen’s PBM Select™ can help speed up the user’s efforts. PBM Select’s customized approach offers flexibility in configuration, timing, and pricing, to improve patient safety and safeguard precious blood resources. The company’s PBM program reduced blood acquisition costs by 43% (patient volume adjusted, single client, 3-year partnership), their solution decreased red blood cell utilization within the first 12 months (large, 14-hospital health system) by 18%. Recently, 3DR Labs, an Accumen Company, announced that it is now offering an artificial intelligence (AI) solution for diagnosing chronic lung disease through a new partnership with Imbio. 3DR Labs customers will have access to Imbio’s AI imaging technology effective immediately. Imbio transforms standard medical images into rich visual maps of a patient’s condition alongside quantitative reports that provide physicians with detailed data about the type and extent of abnormalities found. This technology helps physicians to identify issues that may not be immediately visible in the images, allowing them to make prompt, appropriate treatment decisions for their patients with chronic lung and thoracic conditions. “We are excited to partner with Imbio to bring AI-powered algorithms for image analyses to 3DR’s hospital customers. As health system resources continue to be strained by the COVID-19 pandemic, critical conditions may unfortunately be missed by the human eye and not be diagnosed until the patient experiences a future exacerbation or readmission. Imbio’s technology provides radiologists with another powerful resource to ensure that the diagnosis occurs, and treatment begins, as early in the disease progression as possible,” says Dr. Rob Falk, chief medical officer at 3DR Labs. Accumen also announced a new partnership with icometrix, which will allow it to provide hospitals and health systems nationally with access to the AI-based icobrain software. Icobrain enables radiologists to identify abnormalities and structural changes in the brain of patients with multiple sclerosis, dementia, epilepsy, stroke, and brain trauma with the highest accuracy. Using icobrain can reduce the duration of suboptimal treatment for multiple sclerosis patients from 3.9 to 1.2 years by permitting the inclusion of brain- and lesion volume change findings into their disease management. Accumen continues to support hospitals and health systems nationally, regularly adding new resources to its COVID-19 Resource Center at https://accumen.com/covid-19/#accumenresponsetools.